Precise Cooler for Donor Heart Transport
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT07354763
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Heart Transplantation
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Organ transport using SherpaPak — DEVICEParagonix SherpaPak
- Ryobi cooler for Organ Transport — DEVICEThis is a temperature-controlled cooler without a gel or ice
Study Details
The investigators are doing this study to compare approaches to cold storage of donor hearts during transportation. The adjustable temperature RYOBI cooler should allow precise temperature control while reducing environmental waste and providing a cost savings benefit when compared to the commercially available, FDA-approved Paragonix SherpaPak device.
Key Dates
- Start date
- Apr 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Jan 15, 2027
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Organ transport using Standard of Care Paragonix SherpaPakIn this arm, the organ will be transported using the FDA Approved Sheperpak by Paragonix
- Experimental: Organ transport using the RYOBI cooler.In this arm, the organ will be transported using the Ryobi cooler
Primary Outcome Measure
Incidence of primary graft dysfunction [ Time Frame: From Randomization to 30 days after heart transplantation ]
Central Contacts
- Dominic Emerson, MD310-423-3300
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | 90048 |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsPHASE2 · Enrolling By Invitation · Cedars-Sinai Medical Center · Los Angeles, California
- Belatacept in De Novo Heart TransplantationPHASE2 · Recruiting · NYU Langone Health · New York, New York